The VJ Sessions: Roundtable discussions with leading experts in hemonc

With the absence of in-person meetings this year, the hemonc scientific community has desperately missed the opportunities for its experts to get together and discuss the various advances that have been achieved in diagnosis & therapy.

The VJ Sessions have brought together leading experts virtually to help continue the valuable international collaborations in diseases such as multiple myeloma, CLL, AML, lymphoma, MDS and MPNs. You can view our collection of webinar sessions below at your convenience, as well as being able to listen to podcasts of each session on the go.

Acute Myeloid Leukemia (AML)

► Post-ASH 2020 summary
Naval Daver, David Sallman, Eunice Wang and Amir Fathi

► FLT3+ AML
Naval Daver, Amir Fathi, Jessica Altman, Eunice Wang

► Venetoclax regimens
Naval Daver, Courtney DiNardo, Marina Konopleva,
Andrew Wei

► IDH inhibitors
Amir Fathi, Stephane de Botton, Daniel Pollyea

► Immunotherapy
Marion Subklewe, Naval Daver, David Sallman,
Amer Zeidan

► ASCO & EHA 2020 updates
Naval Daver, Marion Subklewe, Andrew Wei, Amir Fathi

Myelodysplastic Syndromes (MDS)

► MDS diagnosis and prognosis with John Bennett
John Bennett

► Giants in MDS
Amer Zeidan, Peter Greenberg, Mario Cazzola, John Bennett and Ghulam Mufti

► Treating MDS around the world
Amer Zeidan, Anne Mwirigi, David Gomez-Almaguer, Mariana Guaraná, Rishi Dhawan and Iman Aboudallé

► Post-ASH 2020 roundtable discussion
Amer Zeidan, Uwe Platzbecker, Andrew Brunner and Jacqueline Garcia

► Lower risk MDS
Amer Zeidan, Valeria Santini, Rami Komrokji, Olatoyosi Odenike

► Latest updates in MDS
Amer Zeidan, Amy DeZern, Michael Savona, Mikkael Sekeres, David Steensma

Multiple Myeloma

► Post-ASH 2020 UK discussion
Rakesh Popat and Karthik Ramasamy

► Post-ASH 2020 roundtable discussion
Maria-Victoria Mateos, Nina Shah and Thomas Martin

►Managing myeloma in the era of COVID-19
Paul Richardson, María-Victoria Mateos, Evangelos Terpos,
Ajai Chari

► COMy & EHA 2020 updates
Mohamad Mohty, Francesca Gay, Saad Usmani

Chronic Lymphocytic Leukemia (CLL)

► Post-ASH 2020 roundtable discussion
John Gribben, Alessandra Tedeschi, Meghan Thompson and Matthew Davids

► ASCO & EHA 2020 updates
John Gribben, Barbara Eichhorst, Susan O’Brien,
Matthew Davids

Myeloproliferative Neoplasms (MPNs)

► Post-ASH 2020 summary
Ruben Mesa, Claire Harrison, Srdan Verstovsek and Naveen Pemmaraju

► COVID-19, therapeutic strategies and takeaways from the 2020 Texas MPN Workshop
Naveen Pemmaraju, Ruben Mesa, Claire Harrison

Lymphoma

► Post-ASH 2020 UK discussion
Graham Collins and Wendy Osborne

► Post-ASH 2020 roundtable discussion
Stephen Ansell and Graham Collins

► Podcast: Highlights from iwNHL 2020
John Gribben, Stephen Ansell, Peter Borchmann, Martin Hutchings

Amyloidosis

► Post-ASH 2020 roundtable discussion
Morie Gertz, Vaishali Sanchorawala, Raymond Comenzo and Ashutosh Wechalekar

General Hematology

► REGISTER NOW: Post-EBMT Trainee Programme
Nico Gagelmann, Claire Hogan and Yasmina Serroukh

► Post-EBMT roundtable discussion
Christian Chabannon, Nico Gagelmann, Zinaida Peric & Eoila Brissot

► 3rd European EBMT-EHA CAR-T Nursing Programme discussion
Erik Aerts, John Murray, Michelle Kenyon & Rose Ellard

► Post-ASH 2020 transplant roundtable discussion
Bruce Levine and Christian Chabannon

► Managing patients with hematological malignancies in the COVID-19 era
Amer Zeidan, John Mascarenhas, Jan Bewersdorf, Rory Shallis